Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
    • Research Interests
    Combination Therapie...Combination TherapiesLong-Term Survival F...Long-Term Survival Follow-UpUrinary Bladder Neop...Urinary Bladder NeoplasmsAntibody-Drug Conjug...Antibody-Drug ConjugateTumor Regression2022202420212025
    20222024

    Papers共 28 篇Author StatisticsCo-AuthorSimilar Experts

    By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
    时间
    引用量
    主题
    期刊级别
    合作者
    合作机构
    All2024202320222021202020192018
    1997P Novel Biomarker, Ephrinb2 (B2), Predicts Resistance to Treatment and Poor Overall Survival (OS) Metastatic Urothelial Carcinoma (Muc)
    S. Sadeghi,N. Mar,D. Tsao-Wei, I. Siddiqi, D. Freeman, K. Torkko, A. van Bokhoven,T. Flaig, P. Gill,A. Rezazadeh Kalebasty,G.P. Sonpavde, J. Bellmunt
    Annals of Oncology (2024): S1155
    Cited0Views6Bibtex
    0
    6
    A Phase II Clinical Trial of Neoadjuvant Sasanlimab and Stereotactic Body Radiation Therapy As an in Situ Vaccine for Cisplatin Ineligible Muscle Invasive Bladder Cancer
    R. Satkunasivam,B. S. Teh, C. Riveros, K. Lim,C. J. D. Wallis, S. Hu, Z. Melchiode, F. Nikolos, B. J. Miles, D. Kaushik, S. H. Chen, E. Efstathiou, K. S. Chan, N. F. Esnaola,G. P. Sonpavde
    European Urology (2024): S415-S415
    Cited0Views1Bibtex
    0
    1
    Load More
    Author Statistics
    00.20.40.60.81#Papers#CitationH-IndexG-IndexSociabilityDiversityActivity

    #Papers: 28

    #Citation: 113

    H-Index: 4

    G-Index: 10

    Sociability: 5

    Diversity: 1

    Activity: 6

    Loading...
    • 合作者
    • 学生
    • 导师
    Toni Choueiri合作论文数
    Lank Center for Genitourinary (GU) Oncology, Dana-Farber Cancer Institute;Harvard Medical School;Brigham and Women's Hospital5
    Matthew Galsky合作论文数
    The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai;Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai5
    Joaquim Bellmunt合作论文数
    Harvard Medical School;Bladder Cancer Center, Dana Farber Cancer Institute5
    Thomas Powles合作论文数
    University of London;Barts Cancer Centre, St. Bartholomew's Hospital5
    P. Ravi合作论文数
    4
    T. B. Powles合作论文数
    4
    Jens Bedke合作论文数
    4
    Daniel P. Petrylak合作论文数
    Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine;Department of Urology, Yale School of Medicine4
    Zsolt Hepp合作论文数
    Global Health Outcomes Strategy and Research, Allergan Inc4
    McGregor Bradley A合作论文数
    4
    Lee, Jae-lyun合作论文数
    Department of Oncology, Asan Medical Center;Digestive Disease Center, Asan Medical Center;University of Ulsan College of Medicine4
    Jonathan E. Rosenberg合作论文数
    Genitourinary Medical Oncology, Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center 4
    I. Duran合作论文数
    3
    B. Perez Valderrama合作论文数
    3
    X. X. Wei合作论文数
    3
    J. E. Berchuck合作论文数
    3
    T. Hernández Guerrero合作论文数
    3
    L. Kwak合作论文数
    3
    A. Swalduz合作论文数
    3
    D. Castellano合作论文数
    3
    P. LoRusso合作论文数
    3
    j f vibert合作论文数
    3
    Charlene Mantia合作论文数
    3
    Ronac Mamtani合作论文数
    Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania3
    C. Vulsteke合作论文数
    3
    Jonathan Wesley Riess合作论文数
    Department of Internal Medicine, University of California, Davis;Comprehensive Cancer Center, University of California, Davis;School of Medicine, University of California, Davis3
    Nobuaki Matsubara合作论文数
    National Cancer Center Hospital East, National Cancer Center3
    Petros Grivas合作论文数
    Department of Medicine, University of Washington3
    Yohann Loriot合作论文数
    Université Paris-Saclay3
    Afshin Dowlati合作论文数
    Department of Medicine, School of Medicine, Case Western Reserve University;University Hospitals3
    Timothy A. Yap合作论文数
    Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center3
    Antoine Italiano合作论文数
    Institut Bergonié3
    Michiel Van der Heijden合作论文数
    Netherlands Cancer Institute3
    William Novotny合作论文数
    3
    J. P. Sade合作论文数
    2
    B. Bloudek合作论文数
    2
    M. Matsangou合作论文数
    2
    Victor Moreno合作论文数
    2
    Helle Pappot合作论文数
    Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen;DCCC Radiotherapy, Aarhus University Hospital;Onkologisk Klinik, Rigshospitalet2
    C Curran合作论文数
    2
    D. Freeman合作论文数
    2
    C. Wu合作论文数
    2
    E. Calvo合作论文数
    2
    Mauricio Burotto合作论文数
    Center for Cancer Research2
    Bilen Mehmet A合作论文数
    2
    Mark M. Awad合作论文数
    Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School2
    Daniela Purcea合作论文数
    2
    Matthew T Campbell合作论文数
    Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center2
    Yoshihiko Tomita合作论文数
    2
    No result temporarily, you can search similar Scholar with the same research interest
    Data Disclaimer
    The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn